Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1145 | 1031 | 1145 | 972 | 1520 | - |
Fund Return | 14.48% | 3.06% | 14.48% | -0.95% | 8.73% | - |
Place in category | 269 | 258 | 269 | 284 | 238 | - |
% in Category | 54 | 47 | 54 | 62 | 56 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Bridge Builder Large Cap Growth | 27.56B | 21.40 | 5.51 | - | ||
Bridge Builder Large Cap Value | 23.52B | 14.42 | 7.26 | - | ||
Bridge Builder International Equity | 19.44B | 5.67 | 0.53 | - | ||
Bridge Builder Municipal Bond | 16.12B | 2.08 | 0.07 | - | ||
Bridge Builder Small/Mid Cap Value | 8.98B | 12.02 | 5.19 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Principal MidCap Institutional | 14.79B | 19.98 | 5.08 | 12.38 | ||
T. Rowe Price Mid-Cap Growth I | 12.97B | 9.54 | 0.73 | - | ||
Vanguard Mid-Cap Growth Index Admir | 12.51B | 16.41 | 0.66 | 10.40 | ||
T. Rowe Price Mid-Cap Growth | 12.09B | 9.40 | 0.60 | 10.24 | ||
T. Rowe Price New Horizons I | 9.79B | 3.99 | -7.28 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
argenx ADR | US04016X1019 | 1.32 | 639.84 | -1.17% | |
Tradeweb Markets | US8926721064 | 1.26 | 128.57 | +0.52% | |
West Pharmaceutical Services | US9553061055 | 1.19 | 347.87 | +0.92% | |
Tyler Technologies | US9022521051 | 1.00 | 586.03 | +0.25% | |
Spotify Tech | LU1778762911 | 0.94 | 493.56 | +1.24% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review